Table 2.
Comparisons of Glycated Hemoglobin Goal*Achievement Among Hispanic Groups by Treatment Arms
| Intensive Arm | Mexican N = 110 | Puerto Rican N = 105 | Dominican N = 77 | P value |
|---|---|---|---|---|
| N (%) at goal at baseline | 3 (3) | 2 (2) | 1 (1) | 0.88 |
| N (%) ever achieved goal | 81 (74) | 69 (66) | 49 (64) | 0.30 |
| N (%) relapsed from goal† | 53 (65) | 54 (78) | 41(84) | 0.05 |
| Median time to achievement of goal, days‡ | 232 | 250 | 265 | 0.22 |
| Adherence to study visits (%) §|| | 93 | 92 | 90 | 0.25 |
| Standard Arm | Mexican N = 131 | Puerto Rican N = 93 | Dominican N = 71 | p-value |
| N (%) at goal at baseline | 32 (24) | 32 (34) | 22 (31) | 0.25 |
| N (%) ever achieved goal | 119 (91) | 84 (90) | 59 (83) | 0.21 |
| N (%) relapsed from goal† | 81 (68) | 57 (68) | 40 (68) | 0.99 |
| Median time to achievement of goal, days‡ | 120 | 115 | 116 | 0.50 |
| Adherence to study visits (%) §|| | 97 | 96 | 95 | 0.15 |
*Glycated hemoglobin goal is <6.5 for the intensive and 7–7.9 inclusive, for the standard treatment arms
†Ever had a measured glycated hemoglobin >6.5/>7.9 among those who achieved glycated hemoglobin goals in their respective treatment arms
‡ Time to first glycated hemoglobin goal achievement, if value <6.5/7–7.9 inclusive at baseline time to achievement = 0 days.
§ Proportions of scheduled visits that participants attended
|| Denominator includes all scheduled clinic visits up to the last recorded glycated hemoglobin measurement during the trial